Evidence map›Paper›PMID 42413504›Full record

ArticleCell reports methods2026

Framework for evaluating in vitro vasculogenic mimicry using structural and metabolic parameters.

Gema Nicolle Santander, Nicole Babbitt, Javiera Veas-Torres, Macarena Silva-Rojas, Gabriel Mingo, Andrés Valdivia, Alejandra Espinoza, Sofía Salas, Cristóbal Canales, German Cabrera and 24 more

Abstract read
In one paragraph

Article in Cell reports methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Gema Nicolle SantanderDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Nicole BabbittDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Javiera Veas-TorresDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Macarena Silva-RojasDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Gabriel MingoDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Andrés ValdiviaDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Alejandra EspinozaDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Sofía SalasDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Cristóbal CanalesDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
German CabreraDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Anais MuñozDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Josefa FuenzalidaDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Javiera PradenasDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Isidora VegaDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Valentina GeorgeDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Gabriel MaldonadoDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Varina AldanaDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Dusan RacordonDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
Pamela GonzálezDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.
Jose Vasquez-ReyesDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Center for Cancer Prevention and Control (FONDAP-CECAN), Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
Hector R ContrerasCenter for Cancer Prevention and Control (FONDAP-CECAN), Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.
Julio C TapiaInterdisciplinary Nucleus for Biology and Genetics (NiGB), Institute of Biomedical Sciences (ICBM), Faculty of Medicine, University of Chile, Santiago, Chile.
Manuel Varas-GodoyCentro de Biología Celular y Biomedicina (CEBICEM), Facultad de Ciencias, Universidad San Sebastián, Santiago, Chile; Centro Ciencia & Vida, Fundación Ciencia & Vida, Santiago, Chile.
Roger GejmanDepartment of Pathology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Juan Carlos RoaMillennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile; Center for Cancer Prevention and Control (FONDAP-CECAN), Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Pathology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Carolina BizamaMillennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile; Center for Cancer Prevention and Control (FONDAP-CECAN), Pontificia Universidad Católica de Chile, Santiago, Chile; Advanced Center for Chronic Disease (FONDAP-ACCDIS), Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Pathology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Patricia GarcíaCenter for Cancer Prevention and Control (FONDAP-CECAN), Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Pathology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Carolina IbáñezMillennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile; Center for Cancer Prevention and Control (FONDAP-CECAN), Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Hematology and Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile; Centro Del Cáncer UC-Christus, Pontificia Universidad Católica de Chile, Santiago, Chile; Foundación Oncomujer, Santiago, Chile.
Germán OsorioFaculty of Biological Sciences, NeuroCellT and Center for Advanced Microscopy (CMA), University of Concepcion, Concepción, Chile.
Francisco NualartFaculty of Biological Sciences, NeuroCellT and Center for Advanced Microscopy (CMA), University of Concepcion, Concepción, Chile.
Zhongwen ChenInterdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.
Andrea RavasioInstitute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Nucleus on Tissue Self-Organization and Mechanics (SELFO), Santiago, Chile.
Cristina BertocchiDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Nucleus on Tissue Self-Organization and Mechanics (SELFO), Santiago, Chile; Graduate School of Engineering Science, University of Osaka, Osaka, Japan.
Gareth I OwenDepartment of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile; Center for Cancer Prevention and Control (FONDAP-CECAN), Pontificia Universidad Católica de Chile, Santiago, Chile; Advanced Center for Chronic Disease (FONDAP-ACCDIS), Pontificia Universidad Católica de Chile, Santiago, Chile; Department of Hematology and Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. Electronic address: gowen@bio.puc.cl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vasculogenic mimicry (VM) refers to the ability of non-endothelial cells to form fluid-conducting, vessel-like structures independently of endothelial cells. In cancer, VM is associated with tumor aggressiveness and poor prognosis, although similar structures may also be formed by non-cancerous cells. Here, we systematically screened more than 23 human and murine cell lines, including diverse cancer types, fibroblasts, and primary-tumor-derived cells, identifying cell types capable or incapable of VM formation. Using confocal microscopy and 3D reconstruction, we define in vitro VM as the formation of lumen-containing tubular structures by non-endothelial cells, distinguishing this phenomenon from simple cellular clustering or alignment. Importantly, cell types capable of confirmed VM in vitro corresponded closely with previous findings in mouse xenograft models. We further provide a practical protocol for screening VM capacity and demonstrate that cell density, glucose concentration, serum availability, and matrix stiffness are critical environmental determinants of VM formation.

Indexed as

Neovascularization, PathologicAnimalsCell Line, TumorEndothelial CellsFibroblastsGlucoseHumansMiceGlucosecancerCP: cancer biologyglucoseMatrigelmechanobiologystandard assayvasculaturevasculogenic mimicryvessel

Identifiers

PMID42413504
PMCPMC13615505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.